ViaCell is focused in the area of women’s health and conducts R&D to investigate potential therapeutic uses of umbilical cord blood derived stem cells. Acquired by Perkin Elmer in 2007.
Sub Sector: Exits - Healthcare
Moderna pioneers the discovery and development of messenger RNA (mRNA) therapeutics and vaccines, an entirely new class of medicines that directs the body’s cells to produce intracellular or secreted proteins that can have a therapeutic or preventive benefit for both patients and healthy individuals. Listed on NASDAQ in 2018.